Patents Assigned to Altermune, LLC
  • Chemically Programmable Immunity
    Publication number: 20100247535
    Abstract: Methods and compositions for immediately immunizing an individual against any molecule or compound. The present invention comprises an immunity linker with at least two sites; (1) at least one first binding site that binds to an immune response component in an individual that has been pre-immunized with a universal immunogen, and (2) at least one second binding site that binds specifically to a desired compound or molecule, the target.
    Type: Application
    Filed: January 11, 2010
    Publication date: September 30, 2010
    Applicant: Altermune LLC
    Inventor: Kary B. Mullis
  • Chemically programmable immunity
    Patent number: 7645743
    Abstract: Methods and compositions for immediately immunizing an individual against any molecule or compound. The present invention comprises an immunity linker with at least two sites; (1) at least one first binding site that binds to an immune response component in an individual that has been pre-immunized with a universal immunogen, and (2) at least one second binding site that binds specifically to a desired compound or molecule, the target.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: January 12, 2010
    Assignee: Altermune, LLC
    Inventor: Kary B. Mullis
  • Chemically programmable immunity
    Patent number: 7422746
    Abstract: Methods and compositions for immediately immunizing an individual against any molecule or compound. The present invention comprises an immunity linker with at least two sites; (1) at least one first binding site that binds to an immune response component in an individual that has been pre-immunized with a universal immunogen, and (2) at least one second binding site that binds specifically to a desired compound or molecule, the target.
    Type: Grant
    Filed: October 29, 2003
    Date of Patent: September 9, 2008
    Assignee: Altermune, LLC
    Inventor: Kary B. Mullis